{"title": "Sanofi outlines five-pronged approach to reel in \u20ac10B in vaccine sales by 2030", "author": "Fraiser Kansteiner", "url": "https://www.fiercepharma.com/pharma/sanofi-outlines-five-pronged-approach-reel-eu10b-vaccine-sales-2030", "hostname": "fiercepharma.com", "description": "While Dupixent often steals the show, Sanofi isn't sleeping on its vaccine franchise. | By 2030, Sanofi figures its immunizations could generate more than \u20ac10 billion in annual sales, the company said during a vaccines R&D event Thursday. Much of that momentum hinges on Sanofi's pipeline, where the company is targeting an \"accelerated pace of innovation\" in a bid to launch at least five phase 3 vaccine programs by 2025.", "sitename": "FiercePharma", "date": "2023-06-29", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Subscribe Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}